Skip to content

MAZE MAZE Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$333K+405%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.21M+219%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$8.43M+3,472%
Zymeworks logo
ZymeworksZYME
$8.72M+1,029%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$18M
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$60.88M

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's stock issuance proceeds?
MAZE (MAZE) reported stock issuance proceeds of $4.08M in Q1 2026.
How has MAZE's stock issuance proceeds changed year-over-year?
MAZE's stock issuance proceeds increased by 3137.3% year-over-year, from $126K to $4.08M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.